These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8658074)

  • 21. Reduction in the IL-6 level at 24 h after admission to the intensive care unit is a survival predictor for Vietnamese patients with sepsis and septic shock: a prospective study.
    Thao PTN; Tra TT; Son NT; Wada K
    BMC Emerg Med; 2018 Nov; 18(1):39. PubMed ID: 30400775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothermia and cytokines in septic shock. Norasept II Study Investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock.
    Marik PE; Zaloga GP
    Intensive Care Med; 2000 Jun; 26(6):716-21. PubMed ID: 10945388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of tumor necrosis factor α -308G/A and interleukin-6 -174G/C gene polymorphism with pneumonia-induced sepsis.
    Feng B; Mao ZR; Pang K; Zhang SL; Li L
    J Crit Care; 2015 Oct; 30(5):920-3. PubMed ID: 26025100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group.
    Calandra T; Gerain J; Heumann D; Baumgartner JD; Glauser MP
    Am J Med; 1991 Jul; 91(1):23-9. PubMed ID: 1907101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock?
    Routsi C; Giamarellos-Bourboulis EJ; Antonopoulou A; Kollias S; Siasiakou S; Koronaios A; Zakynthinos S; Armaganidis A; Giamarellou H; Roussos C
    Clin Exp Immunol; 2005 Oct; 142(1):62-7. PubMed ID: 16178857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated nucleosome levels in systemic inflammation and sepsis.
    Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
    Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistently low plasma thioredoxin is associated with meningococcal septic shock in children.
    Callister ME; Burke-Gaffney A; Quinlan GJ; Betts H; Nadel S; Evans TW
    Intensive Care Med; 2007 Feb; 33(2):364-7. PubMed ID: 17115131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock.
    Tamayo E; Fernández A; Almansa R; Carrasco E; Heredia M; Lajo C; Goncalves L; Gómez-Herreras JI; de Lejarazu RO; Bermejo-Martin JF
    Eur Cytokine Netw; 2011 Jun; 22(2):82-7. PubMed ID: 21628135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock.
    Pauly D; Hamed S; Behnes M; Lepiorz D; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
    J Crit Care; 2016 Feb; 31(1):68-75. PubMed ID: 26489483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
    Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
    Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis.
    Oda S; Hirasawa H; Shiga H; Nakanishi K; Matsuda K; Nakamua M
    Cytokine; 2005 Feb; 29(4):169-75. PubMed ID: 15652449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.
    Abraham E; Laterre PF; Garbino J; Pingleton S; Butler T; Dugernier T; Margolis B; Kudsk K; Zimmerli W; Anderson P; Reynaert M; Lew D; Lesslauer W; Passe S; Cooper P; Burdeska A; Modi M; Leighton A; Salgo M; Van der Auwera P;
    Crit Care Med; 2001 Mar; 29(3):503-10. PubMed ID: 11373411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death?
    Terregino CA; Lopez BL; Karras DJ; Killian AJ; Arnold GK
    Ann Emerg Med; 2000 Jan; 35(1):26-34. PubMed ID: 10613937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of cytokines kinetics in severe sepsis and its relationship with mortality and score of organic dysfunction].
    Dougnac A; Riquelme A; Calvo M; Andresen M; Magedzo A; Eugenin E; Marshall G; Gutiérrez M
    Rev Med Chil; 2001 Apr; 129(4):347-58. PubMed ID: 11413986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
    Lin WC; Chen CW; Chao L; Chao J; Lin YS
    PLoS One; 2017; 12(5):e0178387. PubMed ID: 28542440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.
    de Werra I; Jaccard C; Corradin SB; Chioléro R; Yersin B; Gallati H; Assicot M; Bohuon C; Baumgartner JD; Glauser MP; Heumann D
    Crit Care Med; 1997 Apr; 25(4):607-13. PubMed ID: 9142024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor necrosis factor, interleukin-6, endotoxin and procalcitonin in septic shock in patients with hematologic neoplasms].
    Galstian GM; Berkovskiĭ AL; Zueva VA; Kariakin AV; Levina AA; Sergeeva EV; Speranskaia LL; Gorodetskiĭ VM
    Ter Arkh; 2002; 74(7):56-61. PubMed ID: 12181838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The systemic inflammatory response in the development of ventilator-associated pneumonia.
    Bonten MJ; Froon AH; Gaillard CA; Greve JW; de Leeuw PW; Drent M; Stobberingh EE; Buurman WA
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1105-13. PubMed ID: 9351609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock.
    Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA
    PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.